Related Experiment Video
Updated: Aug 9, 2025
07:52
Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
10.1K
Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease
Maria-Elpida Christopoulou1, Eleni Papakonstantinou1,2, Daiana Stolz1,2
1Department of Pneumology, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
International Journal of Molecular Sciences
|February 25, 2023
Summary
Matrix metalloproteinases (MMPs) are key enzymes in chronic obstructive pulmonary disease (COPD) pathogenesis, driving airway remodeling and emphysema. Targeting MMPs offers a promising therapeutic strategy for improving lung function in COPD patients.
Area of Science:
- Pulmonology and Respiratory Medicine
- Biochemistry and Molecular Biology
Background:
- Matrix metalloproteinases (MMPs) are enzymes crucial for extracellular matrix degradation.
- Airway remodeling and emphysema, characterized by matrix destruction, are hallmarks of chronic obstructive pulmonary disease (COPD).
- MMPs play a significant role in the pathological processes underlying COPD.
Purpose of the Study:
- To review and evaluate recent literature on the involvement of various MMPs in COPD.
- To examine the regulatory mechanisms of MMP activity by tissue inhibitors.
- To discuss the therapeutic potential of targeting MMPs in COPD management.
Main Methods:
- Comprehensive literature review of recent scientific publications.
- Appraisal of evidence concerning MMPs' roles in COPD pathogenesis.
- Analysis of regulatory mechanisms involving tissue inhibitors of MMPs.
Main Results:
- Specific MMPs are implicated in the airway remodeling and emphysema seen in COPD.
- Tissue inhibitors play a critical role in modulating MMP activity.
- Evidence from clinical trials suggests potential therapeutic benefits of targeting MMPs.
Conclusions:
- MMPs are integral to COPD pathogenesis, contributing to lung structural changes.
- Understanding MMP regulation is key to developing effective COPD therapies.
- Targeting MMPs represents a viable therapeutic avenue for COPD treatment.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
01:23Role of Matrix Metalloproteases in Degradation of ECM
2.4K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K